Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001760854-24-000012
Filing Date
2024-12-12
Accepted
2024-12-12 12:04:42
Documents
7
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 6-K a6-kformmanagerstransactio.htm 6-K 11201
2 EX-99.1 PDMR NOTIFICATIONS PURSUANT TO MAR exhibit991pdmrnotificati.htm EX-99.1 23231
3 exhibit991pdmrnotificati001.jpg GRAPHIC 94970
4 exhibit991pdmrnotificati002.jpg GRAPHIC 75896
5 exhibit991pdmrnotificati003.jpg GRAPHIC 115319
6 exhibit991pdmrnotificati004.jpg GRAPHIC 84096
7 exhibit991pdmrnotificati005.jpg GRAPHIC 66393
  Complete submission text file 0001760854-24-000012.txt   637187
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 241543865
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)